Julia Catini

Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy

M. Mercuri, M. Maurer, P. García-Pavía, 2022, Frontiers in Cardiovascular Medicine.

The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia

D. Hilleman, D. Anzalone, J. Backes, 2016, Lipids in Health and Disease.

Statins in Chronic Kidney Disease: When and When Not to Use Them.

N. Vaziri, D. Anzalone, Julia Catini, 2016, The Journal of family practice.

SAFETY AND TOLERABILITY OF CAEL-101, AN ANTI-AMYLOID MONOCLONAL ANTIBODY, IN COMBINATION WITH PLASMA CELL DYSCRASIA THERAPY IN PATIENTS WITH LIGHT-CHAIN AMYLOIDOSIS: RESULTS FROM A PHASE 2 STUDY

M. Liedtke, J. Zonder, C. Quarta, 2022, Journal of the American College of Cardiology.

The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia

D. Hilleman, D. Anzalone, J. Backes, 2016, Lipids in Health and Disease.